(RCB0992) HOS

A cell line, supplied by RIKEN Bioresource Center Cell Bank, expressed in Homo sapiens, cited in 10 publications, with 12 published images. Applications used include ICC-IF and IHC.

Go to:

12 images

10 citations

General Information

Supplier

RIKEN Bioresource Center Cell Bank

Model Type

Cell line

Species

Homo sapiens (Human)

Cell Line

HOS

Organ

Bone

Disease

Osteosarcoma

View additional product information

Comments

for this reagent

Add your comment here...

Enabling you to share comments privately within your lab, helping to avoid duplicated effort.

Get free early access and help us shape this new feature. Join the private beta

12 images

10 citations

found in the literature

Single-cell fixed RNA profiling of the osteosarcoma clinical Spectrum identifies ADAMTS12 and RNASE1 as key drivers of the metastatic niche.

View PDF

In Journal of Bone Oncology on 1 August 2026 by Van Khanh, N., Dung, T. T., et al.

Air Plasma-Activated Medium Evokes a Death-Associated Perinuclear Mitochondrial Clustering.

View Preprint View PDF

In International Journal of Molecular Sciences on 20 January 2022 by Suzuki-Karasaki, M., Ando, T., et al.

Images:

Shape-memory balloon offering simultaneous thermo/chemotherapies to improve anti-osteosarcoma efficacy.

View PDF

In Biomaterials Science on 12 October 2021 by Ouchi, S., Niiyama, E., et al.

Combined Anticancer Effect of Plasma-Activated Infusion and Salinomycin by Targeting Autophagy and Mitochondrial Morphology.

View PDF

In Frontiers in Oncology on 22 June 2021 by Ando, T., Suzuki-Karasaki, M., et al.

Images:

Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis.

View PDF

In Cancers on 23 October 2020 by Ando, T., Ichikawa, J., et al.

Aspirin Induces Mitochondrial Ca2+ Remodeling in Tumor Cells via ROS‒Depolarization‒Voltage-Gated Ca2+ Entry.

View PDF

In International Journal of Molecular Sciences on 5 July 2020 by Fujikawa, I., Ando, T., et al.

Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.

View Preprint View PDF

In BMC Cancer on 8 January 2020 by Yoshida, K., Okamoto, M., et al.

Autophagy inhibitors regulate TRAIL sensitivity in human malignant cells by targeting the mitochondrial network and calcium dynamics.

View PDF

In International Journal of Oncology on 1 May 2019 by Onoe-Takahashi, A., Suzuki-Karasaki, M., et al.

Cold PSM, but not TRAIL, triggers autophagic cell death: A therapeutic advantage of PSM over TRAIL.

View PDF

In International Journal of Oncology on 1 August 2018 by Ito, T., Ando, T., et al.

Plasma-stimulated medium kills TRAIL-resistant human malignant cells by promoting caspase-independent cell death via membrane potential and calcium dynamics modulation.

View PDF

In International Journal of Oncology on 1 March 2018 by Tokunaga, T., Ando, T., et al.

Is this your product?

Claim your listing to maximise exposure of your products to the hundreds of thousands of researchers that use CiteAb.

Claim my listing

Custom Cell Lines

If you can't find the cell line you're looking for, why not consider a custom reagent from one of these suppliers.

Custom cell line suppliers

Calculators

A collection of useful calculators with more to come!

Use dilution calculator

Report a Problem

Spotted a mistake? Please let us know so that we can put it right!

Report a problem

(RCB0992) HOS

General Information

Additional product information

Supplier also known as

Comments

for this reagent

12 images

10 citations

found in the literature

Is this your product?

Custom Cell Lines

Calculators

Report a Problem

(RCB0992) HOS

General Information

Additional product information

Supplier also known as

Comments for this reagent

12 images 10 citations found in the literature

Is this your product?

Custom Cell Lines

Calculators

Report a Problem

Join thousands of people who already enjoy the CiteAb newsletter

Comments

for this reagent

12 images

10 citations

found in the literature